Kesmalea Therapeutics Limited
- Company number
- 12961631
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 20 Oct 2020
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ROSTOM, Raghd, Dr | Director | 6 Nov 2025 | |
| CLACKSON, Timothy Piers, Dr | Director | 9 May 2025 | |
| FINCH, Harry | Director | 20 Oct 2020 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Harry Finch | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
20 Oct 2020 | 8 Sep 2022 |
| Syncona Limited | Ownership Of Shares 50 To 75 Percent Voting Rights 50 To 75 Percent |
8 Sep 2022 |
Accounts
| Year ended | Net assets | Employees |
|---|---|---|
| 31 Mar 2025 | - | - |
| 31 Mar 2024 | - | - |
| 31 Mar 2023 | - | - |
| 31 Mar 2022 | £1,400 | 0 |
| 31 Oct 2021 Dormant | £5,000 | 0 |
Connections
Directors’ other companies
- ROSTOM, Raghd, Dr - Director at Keystrand Therapeutics Limited